RBM28 · Western blot design guide

RBM28 Western Blot Planning Guide

Plan a RBM28 Western blot around the catalog-observed 85.7 kDa band, image-backed A09394-1 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RBM28 (RBM28): expected band 85.7 kDa, antibody A09394-1, and PMC-cited SDS-PAGE protocol steps
RBM28 Western blot protocol sheet — expected band 85.7 kDa, antibody A09394-1, controls and PMC citations. Open the full RBM28 WB guide →

RBM28 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 85.7 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Fallopian tube
Negative control ⓘ Salivary gland
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 85.7 kDa
ⓘ Localization Nucleus, nucleolus
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human
Section 1

Real Curated RBM28 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateBronchus
Gel %8-10%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA09394-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected RBM28 Western Blot Band Size?

Use the product-observed 85.7 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
85.7 kDaMatches the authoritative product WB observation.
85.7 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected RBM28 appearancePlan around 85.7 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band85.7 kDa; use this as the primary experimental expectation.
Calculated mass85.7 kDa from UniProt Q9NW13; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A09394-1.
Why is my band missing or off?
SituationLikely causeNext action
85.7 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for RBM28 Western blot

🧪Use Fallopian tube as the first positive-control candidate and Salivary gland as the HPA Not detected negative candidate.
Positive control: Fallopian tube (High)
Negative control: Salivary gland (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for RBM28

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Fallopian tube Reported tissue cells High Protein (HPA) HPA →
Cerebellum Reported tissue cells High Protein (HPA) HPA →
Caudate Reported tissue cells High Protein (HPA) HPA →
Bronchus Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Salivary gland Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced RBM28 Western Blot Tips

Deeper troubleshooting and optimisation questions for RBM28, answered from its protein features.

Which band should guide the blot?
Use 85.7 kDa, the observation attached to the authoritative A09394-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 85.7 kDa expectation.
Which positive control should I start with?
Start with Fallopian tube, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Salivary gland as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for RBM28 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A09394-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC8789582, PMC11573713, PMC6471994.
Boster reagents

RBM28 Western Blot Reagents

Human-reactive RBM28 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for RBM28 using A09394-1; observed band 85.7 kDa
Anti-RBM28 Antibody Picoband®
Cat # A09394-1

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.